Add BrightSurf on Google Email

Science News for November 8, 2026


Single-cell and spatial multiomics reveal microglia-mural interactions involved in notoginsenoside R1 protection against experimental ischemic stroke

Researchers discovered NGR1's neuroprotective effects are mediated by microglia-mural interactions and a FOXO1-associated program involving ABCA9. This study provides single-cell resolved insights into NGR1's mechanism and identifies potential therapeutic targets for cerebral blood flow regulation.

SourceInternational Society for Health Data Science·JournaliMetaMed·TypeExperimental study·DateNov 8, 2026

Underwater record of “hidden” disasters discovered

Researchers at the University of Tokyo used a new radiocarbon analysis technique to study ocean sediment cores, revealing previously undetected history of geophysical disasters in Japan. The study found multiple 'hidden' traces of earthquakes in the Nankai Trough, which could help predict future geophysical events and prepare for poten...

SourceUniversity of Tokyo·JournalRadiocarbon·TypeObservational study·DateNov 8, 2026

Experimental weight-loss drug eases painful knee osteoarthritis in two clinical trials

Phase 3 clinical trials involving over 1,000 participants found that those taking retatrutide, a new experimental weight-loss injectable drug, lost about a quarter of their body weight on average and experienced significant pain relief. The drug also showed benefits in reducing blood pressure, lipid levels, and systemic inflammation.

SourceNorthwestern University·JournalNew England Journal of Medicine·DateNov 8, 2026

Cleaner bedroom air may help manage blood sugar in prediabetes

A new study found that using portable air filters with high-efficiency particulate air (HEPA) filters can reduce daily blood sugar swings and morning sugar surges in people with prediabetes. By cutting levels of tiny air particles by 36%, cleaner air was linked to a nearly 8% drop in blood sugar swings and smaller morning surges.

SourceNYU Langone Health / NYU Grossman School of Medicine·TypeRandomized controlled/clinical trial·DateNov 8, 2026